Externally applied static magnetic field enhances cardiac retention and functional benefit of magnetically iron-labeled adipose-derived stem cells in infarcted hearts

Stem Cells Translational Medicine

Volumn 5, Issue 10, 2016, Pages 1380-1393

  Wang, Jian ^a,b,c   Xiang, Bo ^b,d   Deng, Jixian ^b,c   Lin, Hung Yu ^b   Zheng, Dayang ^b,c,e   Freed, Darren H ^b,c,f   Arora, Rakesh C ^b,c,g   Tian, Ganghong ^b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^f UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^g ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Adipose derived stem cells; Cell retention; Myocardial infarction; Static magnetic field; Superparamagnetic iron oxide

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL TRANSPLANTATION; CYTOKINE RELEASE; FLOW CYTOMETRY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; IMMUNOFLUORESCENCE TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAGNET; MAGNETIC FIELD; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE CONTRAST MICROSCOPY; RAT; SUBCUTANEOUS FAT; ADIPOSE TISSUE; ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DISEASE MODEL; FEMALE; MALE; PILOT STUDY; PROCEDURES; STEM CELL; STEM CELL TRANSPLANTATION; TRANSGENIC RAT;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; FERRIC COMPOUNDS; FLOW CYTOMETRY; MAGNETIC FIELDS; MALE; METAL NANOPARTICLES; MYOCARDIAL INFARCTION; PILOT PROJECTS; RATS; RATS, TRANSGENIC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84988650141     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0220     Document Type: Article

References (35)

1. Planat-Benard V, Silvestre JS, Cousin B et al. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 2004; 109: 656-663.
2. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7: 211-228.
3. De Ugarte DA, Morizono K, Elbarbary A et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174: 101-109.
4. Ning H, Liu G, Lin G et al. Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med 2009; 6: 967-979.
5. Rodríguez LV, Alfonso Z, Zhang R et al. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 2006; 103: 12167-12172.
6. Sadat S, Gehmert S, Song YH et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF.Biochem Biophys Res Commun 2007; 363: 674-679.
7. Rehman J, Traktuev D, Li J et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-1298.
8. Wang L, Deng J, Tian W et al. Adiposederived stem cells are an effective cell candidate for treatment of heart failure: An MR imaging study of rat hearts. Am J Physiol Heart Circ Physiol 2009; 297: H1020-H1031.
9. Bai X, Yan Y, Song YH et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 2010; 31: 489-501.
10. Valina C, Pinkernell K, Song YH et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007; 28: 2667-2677.
11. Perin EC, Sanz-Ruiz R, Sánchez PL et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. Am Heart J 2014; 168: 88-95.e2.
12. Hou D, Youssef EA, Brinton TJ et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005; 112(suppl): I150-I156.
13. Li SH, Lai TY, Sun Z et al. Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 2009; 137: 1225-33.e1.
14. Yasuda T, Weisel RD, Kiani C et al. Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction. J Thorac Cardiovasc Surg 2005; 129: 904-911.
15. Lübbe AS, Bergemann C, Huhnt W et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res 1996; 56: 4694-4701.
16. Lübbe AS, Bergemann C, Riess H et al. Clinical experiences 14 patients with advanced solid tumors. Cancer Res 1996; 56: 4686-4693.
17. Goodwin SC, Bittner CA, Peterson CL et al. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci 2001; 60: 177-183.
18. Muthana M, Scott SD, Farrow N et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther 2008; 15: 902-910.
19. Castaneda RT, Khurana A, Khan R et al.. Labeling stem cells with ferumoxytol, an FDAapproved iron oxide nanoparticle.. J Vis Exp 2011 (57): e3482.
20. Renshaw PF, Owen CS, McLaughlin AC et al. Ferromagnetic contrast agents: A new approach. Magn Reson Med 1986; 3: 217-225.
21. Wang L, Deng J, Wang J et al. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxideenhanced magnetic resonance imaging identifies viable cells. Magn Reson Imaging 2009; 27: 108-119.
22. Blaber SP, Hill CJ, Webster RA et al. Effect of labeling with iron oxide particles or nanodiamonds on the functionality of adipose-derived mesenchymal stem cells. PLoS One 2013; 8: e52997.
23. Terrovitis J, Stuber M, Youssef A et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008; 117: 1555-1562.
24. Viktora L, Fiala J, Petz R. Effect of prolonged exposure to a magnetic field on the haematopoietic stemcell. Physiol Bohemoslov 1976; 25: 359-364.
25. Schäfer R, Bantleon R, Kehlbach R et al. Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles. BMC Cell Biol 2010; 11: 22.
26. Reddig A, Fatahi M, Friebe B et al. Analysis of DNA double-strand breaks and cytotoxicity after 7 Tesla magnetic resonance imaging of isolated human lymphocytes. PLoS One 2015; 10: e0132702.
27. Chaudeurge A, Wilhelm C, Chen-Tournoux Aet al. Canmagnetic targeting ofmagnetically labeled circulating cells optimize intramyocardial cell retention? Cell Transplant 2012; 21: 679-691.
28. Cheng K, Malliaras K, Li TS et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant 2012; 21: 1121-1135.
29. Huang Z, Shen Y, Sun A et al. Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Stem Cell Res Ther 2013; 4: 149.
30. Teng CJ, Luo J, Chiu RC et al. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 2006; 132: 628-632.
31. Cheng K, Li TS, Malliaras K et al. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010; 106: 1570-1581.
32. Bai X, Yan Y, Coleman M et al. Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging. Mol Imaging Biol 2011; 13: 633-645.
33. Pouzet B, Vilquin JT, Hagege AA et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 2001; 71: 844-850; discussion 850-851.
34. Henning RJ, Burgos JD, Vasko M et al. Human cord blood cells and myocardial infarction: Effect of dose and route of administration on infarct size. Cell Transplant 2007; 16: 907-917.
35. Perin EC, Silva GV, Assad JA et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 2008; 44: 486-495.